We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+15.63%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$925M
AUM Growth
+$121M
Cap. Flow
-$1.06M
Cap. Flow %
-0.11%
Top 10 Hldgs %
22.31%
Holding
255
New
7
Increased
77
Reduced
98
Closed
5

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$6.4M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.73M
3
CVS icon
CVS Health
CVS
+$2.43M
4
MSFT icon
Microsoft
MSFT
+$2.14M
5
V icon
Visa
V
+$1.6M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.75M
2
CELG
Celgene Corp
CELG
+$5.4M
3
AL
Air Lease Corp
AL
+$2.84M
4
AMT icon
American Tower
AMT
+$1.93M
5
KMI icon
Kinder Morgan
KMI
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 16.89%
2 Technology 16.36%
3 Industrials 11.15%
4 Consumer Staples 8.91%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
51
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$5.87M 0.63%
64,820
+32,081
+98% +$2.73M
CSCO icon
52
Cisco
CSCO
$479B
$5.16M 0.56%
95,635
+363
+0.4% +$17.6K
PM icon
53
Philip Morris
PM
$295B
$5.02M 0.54%
56,745
-150
-0.3% -$12.1K
EEM icon
54
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$4.89M 0.53%
113,868
– –
CVX icon
55
Chevron
CVX
$366B
$4.86M 0.52%
39,417
+418
+1% +$49.5K
PFE icon
56
Pfizer
PFE
$153B
$4.77M 0.52%
118,413
-276
-0.2% -$11.1K
INTC icon
57
Intel
INTC
$513B
$4.63M 0.5%
86,320
-615
-0.7% -$31.2K
JPM icon
58
JPMorgan Chase
JPM
$950B
$4.54M 0.49%
44,891
+395
+0.9% +$40.7K
GLNG icon
59
Golar LNG
GLNG
$5.13B
$4.48M 0.48%
212,516
+16,842
+9% +$371K
CLX icon
60
Clorox
CLX
$12.7B
$4.47M 0.48%
27,854
+210
+0.8% +$32.6K
LKQ icon
61
LKQ Corp
LKQ
$6.29B
$4.45M 0.48%
156,876
+3,351
+2% +$90.2K
CELG
62
DELISTED
Celgene Corp
CELG
$4.39M 0.47%
46,565
-61,745
-57% -$5.4M
BDX icon
63
Becton Dickinson
BDX
$48.7B
$4.29M 0.46%
17,594
+2,481
+16% +$586K
EOG icon
64
EOG Resources
EOG
$70.7B
$4.1M 0.44%
43,109
+9,152
+27% +$872K
SSNC icon
65
SS&C Technologies
SSNC
$18.6B
$4M 0.43%
62,839
+17,869
+40% +$994K
HD icon
66
Home Depot
HD
$355B
$3.98M 0.43%
20,760
+560
+3% +$103K
CRM icon
67
Salesforce
CRM
$158B
$3.94M 0.43%
24,871
+1,505
+6% +$233K
LOW icon
68
Lowe's Companies
LOW
$125B
$3.9M 0.42%
35,635
-633
-2% -$63.2K
SHW icon
69
Sherwin-Williams
SHW
$89.8B
$3.88M 0.42%
27,045
-177
-0.7% -$24.6K
KO icon
70
Coca-Cola
KO
$375B
$3.76M 0.41%
80,153
-214
-0.3% -$10K
IFF icon
71
International Flavors & Fragrances
IFF
$21.9B
$3.72M 0.4%
28,910
+9,317
+48% +$1.24M
LECO icon
72
Lincoln Electric
LECO
$15.4B
$3.63M 0.39%
43,244
– –
VTI icon
73
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$3.51M 0.38%
24,247
+1,428
+6% +$199K
RPM icon
74
RPM International
RPM
$15B
$3.45M 0.37%
59,473
+1,000
+2% +$56.8K
MO icon
75
Altria Group
MO
$114B
$3.43M 0.37%
59,793
-3,150
-5% -$161K
1 2
3
4 5

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Family Office held 255 positions worth $925M, up 15% from $804M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.7%. Boston Family Office opened 7 new positions and exited 5, leaving the 255-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q1 2019 buy was Enanta Pharmaceuticals: 2,750 shares worth $263K.
  • Boston Family Office added most to Air Products & Chemicals in Q1 2019, an estimated $6.4M increase.
  • Boston Family Office's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $5.4M.
  • Boston Family Office fully exited Linde in Q1 2019, selling an estimated $7.75M.
  • Boston Family Office's ten largest holdings make up 22% of its $925M portfolio in Q1 2019.
  • Boston Family Office opened 7 new positions and closed 5 in Q1 2019.
  • Boston Family Office's portfolio value rose 15% quarter-over-quarter to $925M.

Based on Boston Family Office's 13F filing for Q1 2019, filed 9 May 2019.